Stockholm, April 3 2014 — NASDAQ OMX (NASDAQ:NDAQ) announced that Recipharm AB (short name: RECI B), a Mid Cap company within the Healthcare sector, today started trading of its shares on the main market of NASDAQ OMX Stockholm. Recipharm is the sixth company to list at NASDAQ OMX’s Nordic main markets in 2014 (NASDAQ OMX Stockholm; Helsinki; Copenhagen and Iceland).
Recipharm is one of Europe’s leading pharmaceutical Contract Development and Manufacturing Organisations (CDMO). Recipharm supplies the global pharmaceuticals market with hundreds of different products in multiple dosage forms including solid dose, semi solids, steriles (liquids and freeze dried), beta-lactams, hormones, dry powder metered dose inhalers, oral liquids and granulates, from facilities across Europe. Headquartered in Sweden, Recipharm employs some 1,500 employees and with a sales turnover in excess of SEK 2.1 bn. The company operates development and manufacturing facilities in Sweden, France, the UK, Germany and Spain. For more information, visit www.recipharm.com.
“Today marks the beginning of a new phase in Recipharm’s life. We welcome all our new shareholders who have demonstrated their confidence in the company and its strategy for growth,” said Thomas Eldered, CEO of Recipharm. “As a listed company with a new access to the capital markets, I am confident that Recipharm now will be able to even more forcefully participate in the consolidation of the CMDO market.”
“We congratulate Recipharm on their IPO and welcome them to NASDAQ OMX and our healthcare sector,” said Adam Kostyal, Senior Vice President at NASDAQ OMX. “We continue to see significant interest among healthcare companies looking to raise captal in the public market, and Recipharm’s listing today underlines that trend.”
To view a CEO interview from the Recipharm listing ceremony click here.
About NASDAQ OMX Group
NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, NASDAQ OMX enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 80 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. NASDAQ OMX is home to more than 3,200 listed companies with a market value of over $8 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaqomx.com.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about futures products to be traded on NFX and NASDAQ OMX's other products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
Media Relations Contact:
+46 (0) 8 405 6639